When Growth Comes From Trading Up, Not Showing Up - Scorecard - MDSpire

When Growth Comes From Trading Up, Not Showing Up

  • By

  • Alysse Henkel

  • Alysse Henkel

  • January 1, 2026

  • 4 min

Share

Clinical Scorecard: When Growth Comes From Trading Up, Not Showing Up

At a Glance

CategoryDetail
ConditionMarket dynamics in the optical industry
Key MechanismsShift towards value-driven decision-making among consumers
Target PopulationEyecare providers and consumers in the optical market
Care SettingEyecare practices

Key Highlights

  • US optical market value reached $69.5 billion in 2025, up 4.4% year over year
  • Declines in patient visits and product volume despite increased spending
  • Consumers are willing to trade up for perceived benefits
  • Replacement cycles lengthened for patients without vision benefits
  • Sunglasses category saw both value and unit volume growth

Guideline-Based Recommendations

Diagnosis

  • Assess patient needs and preferences to guide product recommendations

Management

  • Focus on value-driven conversations and curated product options

Monitoring & Follow-up

  • Track patient spending patterns and preferences over time

Risks

  • Potential for decreased patient visits impacting revenue

Patient & Prescribing Data

Patients in the US optical market

Patients are selective about spending, opting for premium options when benefits are clear

Clinical Best Practices

  • Anchor conversations in patient values
  • Present fewer, well-defined options
  • Make upgrades tangible with demonstrations and comparisons

References

Original Source(s)

Related Content